Articles

Lilly looks to autoimmune drugs

Two local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune
diseases: The costs of treating them are growing twice as fast as the prescription drug market.

Read More

Health care reform dead; long live reform

Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health
care industry, reform is a reality that isn’t going to die.

Read More

Health care Q&A: Greg Pemberton

Greg Pemberton, a health care attorney at Ice Miller LLP, discussed the biggest changes he expects to come out of the federal
health reform bills. “It’s not going to be business as usual,” he said.

Read More

State Republicans try to block health reform mandates

Joint resolutions in the state Legislature seek to amend the state constitution to block enforcement of provisions in the
federal bills that would require individuals to buy insurance and all but the smallest employers to help pay for it.

Read More

Group: Blame policies for smoking

When it comes to encouraging smokers to quit, Indiana just isn’t getting it done. That’s the upshot
of a report card issued Tuesday by the American Lung Association.

Read More

Roche taps new local CEO

Roche Diagnostics named a new CEO for its North American operations Tuesday to replace Michael Tillmann, who resigned on Friday.

Read More